Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice

BACKGROUND: Doxorubicin (DOX) is widely used as an effective chemotherapeutic agent for cancers; however, DOX induces cardiac toxicity, called DOX-induced cardiomyopathy. Although DOX-induced cardiomyopathy is known to be associated with a high cumulative dose of DOX, the mechanisms of its long-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Furihata, Takaaki, Maekawa, Satoshi, Takada, Shingo, Kakutani, Naoya, Nambu, Hideo, Shirakawa, Ryosuke, Yokota, Takashi, Kinugawa, Shintaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103594/
https://www.ncbi.nlm.nih.gov/pubmed/33962676
http://dx.doi.org/10.1186/s40360-021-00495-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103594/
https://www.ncbi.nlm.nih.gov/pubmed/33962676
http://dx.doi.org/10.1186/s40360-021-00495-w

Ejemplares similares